Cytokines sit at the crossroads of immunology, biotechnology, and therapeutic innovation. They are signaling proteins with outsized influence: modulating immune responses, orchestrating cellular communication, and increasingly becoming the backbone of modern biologics. For Contract Development and Manufacturing Organizations (CDMOs), cytokines represent both an opportunity and a challenge. They promise lucrative markets in regenerative medicine, oncology, […]